Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
The Oncologist
|
August 29, 2019
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China
Xiaozhe Li, Wenming Chen, Yin Wu, et al.
Frontiers in Oncology
|
September 20, 2021
Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study
Ning Li, Wenying Deng, Guifang Zhang, et al.
Bone Marrow Transplantation
|
December 7, 2018
Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion
Juanjuan Zhao, Yingling Zu, Lijie Han, et al.
Cancer Medicine
|
July 20, 2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma
Wenjiao Tang, Yan Li, Li Zhang, et al.
Journal for Immunotherapy of Cancer
|
August 15, 2020
Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus
Lu Han, Jian Zhou, Keshu Zhou, et al.
American Journal of Hematology
|
January 22, 2025
CM313 Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma or Marginal Zone Lymphoma: A Multicenter, Phase 1 Dose-Escalation and Dose-Expansion Trial
Huixing Zhou, Zhongxia Huang, Baijun Fang, et al.
Scientific Reports
|
January 9, 2021
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA
Yingling Zu, Jian Zhou, Yuewen Fu, et al.
Leukemia Research
|
March 27, 2007
Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib
Baijun Fang, Yongping Song, Zhengtao Han, et al.
Frontiers in Oncology
|
June 18, 2025
Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review
Zhen Li, Sujing Zhuang, Ruirui Gui, et al.
Frontiers in Oncology
|
May 31, 2023
A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy
Zhenghua Huang, Zhen Li, Juan Wang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
The Oncologist
|
August 29, 2019
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China
Xiaozhe Li, Wenming Chen, Yin Wu, et al.
Frontiers in Oncology
|
September 20, 2021
Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study
Ning Li, Wenying Deng, Guifang Zhang, et al.
Bone Marrow Transplantation
|
December 7, 2018
Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion
Juanjuan Zhao, Yingling Zu, Lijie Han, et al.
Cancer Medicine
|
July 20, 2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma
Wenjiao Tang, Yan Li, Li Zhang, et al.
Journal for Immunotherapy of Cancer
|
August 15, 2020
Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus
Lu Han, Jian Zhou, Keshu Zhou, et al.
American Journal of Hematology
|
January 22, 2025
CM313 Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma or Marginal Zone Lymphoma: A Multicenter, Phase 1 Dose-Escalation and Dose-Expansion Trial
Huixing Zhou, Zhongxia Huang, Baijun Fang, et al.
Scientific Reports
|
January 9, 2021
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA
Yingling Zu, Jian Zhou, Yuewen Fu, et al.
Leukemia Research
|
March 27, 2007
Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib
Baijun Fang, Yongping Song, Zhengtao Han, et al.
Frontiers in Oncology
|
June 18, 2025
Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review
Zhen Li, Sujing Zhuang, Ruirui Gui, et al.
Frontiers in Oncology
|
May 31, 2023
A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy
Zhenghua Huang, Zhen Li, Juan Wang, et al.
Page
of 9